Résultats de la recherche - 46 results

Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.

0.78-0.97; ratio for LSIL, 0.86; 95% CI, 0.80-0.93). In contrast, the specificity of p16 staining was substantially higher with relative specificities of 1.60 (95% CI, 1.35-1.88) and 2.29 (95% CI, 2.05-2.56) ...

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.

Karsten; Schneider, Achim; Kaufmann, Andreas; Petry, K Ulrich; Axel P A Schäfer; Pawlita, Michael; Weis, Joachim; Mehnert, Anja; Fehr, Mathias; Grimm, Christoph; Reich, Olaf; M. Arbyn; Kleijnen, Jos; ...

Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia

Adam; Butler, Katherine; Darlington-Brown, Jessica; Hui, Harriet; Brotherton, Julia; Skinner, Rachel; Brand, A; Roeske, Lara; Heley, Stella; Carter, Jonathan; Bateson, Deborah; Frazer, Ian; Garland, ...

Assessing factors associated with long-term work disability after cancer in Belgium: a population-based cohort study using competing risks analysis with a 7-year follow-up

entering the work disability system for 11 cancer sites using the Fine and Gray model allowing for competing risks. RESULTS The overall median time of work disability was 1.59 years (95%CI 1.52 to 1.66), ...

Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.

whole female population were obtained from the two cancer registries. During 2008-2011, 565153 smears were performed in 498913 women aged 25-64 years, representing an average of 1.13 smears/woman and ...

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

0.97 to 1.02). However, hrHPV assays based on signal amplification were less sensitive on self samples (pooled ratio 0.85, 95% confidence interval 0.80 to 0.89). The specificity to exclude CIN2 + was 2% ...

Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.

those associated with vaccine HPV types and any cervical precancer. Exposure groups were: women aged: 15-26 or 24-45 years being initially negative for high-risk HPV (hrHPV) or negative for the vaccine ...

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.

specificity of 1.00 (95% CI, 0.99 to 1.01) (value of >0.05 in all cases). Regardless of the clinical outcome (CIN2 + or CIN3 +), age restriction (women ≥30 years old), or comparator test used, Anyplex ...

QR code

QR code for this page URL